Format

Send to

Choose Destination
Biomark Med. 2019 Jun 3. doi: 10.2217/bmm-2018-0468. [Epub ahead of print]

Placental exosomes viewed from an 'omics' perspective: implications for gestational diabetes biomarkers identification.

Author information

1
Department of Biochemistry, Medicine Faculty, Universidad Autónoma de San Luis Potosí, San Luis Potosí, PC 78210, Mexico.
2
MicroRNAs Laboratory, Unidad Académica de Ciencias Biológicas, Universidad Autónoma de Zacatecas, Zacatecas, PC 98610, Mexico.
3
Department of Rheumatology & Pathology, Hospital Central 'Dr. Ignacio Morones Prieto,' Universidad Autónoma de San Luis Potosí, San Luis Potosí, PC 78210, Mexico.
4
CONACyT-Universidad Autónoma de Zacatecas, Unidad Académica de Ciencias Biológicas, Zacatecas, PC 98610, Mexico.

Abstract

Exosomes are defined as extracellular vesicles that are released from cells upon fusion of an intermediate endocytic compartment - the multivesicular body - with the plasma membrane. Recently, placenta-derived exosomes have gained special attention, since they play a crucial role in the communication between the mother and fetus. It is known that the concentration of placenta-derived exosomes in the maternal bloodstream is higher in patients with preeclampsia or gestational diabetes mellitus. However, their composition in terms of the content of proteins, nucleic acids or lipids is uncertain. In this work, we reviewed the recent advances in placental exosomes characterization through omics-based methods, and their potential to predict gestational diabetes mellitus.

KEYWORDS:

biomarkers; exosomes; extracellular vesicles; gestational diabetes mellitus; lipidomics; miRNAs; placenta; pregnancy; proteomic; transcriptomics

PMID:
31157549
DOI:
10.2217/bmm-2018-0468

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center